INFLUENZA A VIRUS A/Victoria/4897/2022 IVR-238 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/Croatia/10136RV/2023 X-425A ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/MICHIGAN/01/2021 ANTIGEN (FORMALDEHYDE INACTIVATED) 15 ug / .5mL; 15 ug / .5mL; 15 ug / .5mL; 15 ug / .5mL Injection 5 mL (Fluzone Quadrivalent Northern Hemisphere)
Comprehensive product details for sourcing and verification.
| NDC 11 | 49281-0541-15 |
|---|---|
| Product NDC | 49281-0541 |
| Generic Drug Name | INFLUENZA A VIRUS A/Victoria/4897/2022 IVR-238 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/Croatia/10136RV/2023 X-425A ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/MICHIGAN/01/2021 ANTIGEN (FORMALDEHYDE INACTIVATED) |
| Brand Name | Fluzone Quadrivalent Northern Hemisphere |
| Manufacturer | Sanofi Pasteur Inc. |
| Strength | 15 ug / .5mL; 15 ug / .5mL; 15 ug / .5mL; 15 ug / .5mL |
| Dosage Form | Injection |
| Drug Type | Intramuscular |
| Package Quantity | 1 Vial, Multi-Dose |
| Package Description | 1 VIAL, MULTI-DOSE in 1 PACKAGE (49281-541-15) / 5 mL in 1 VIAL, MULTI-DOSE (49281-541-78) |
| Active Ingredients | Influenza A Virus A/Croatia/10136Rv/2023 X-425A (H3N2) Antigen (Formaldehyde Inactivated); Influenza A Virus A/Victoria/4897/2022 Ivr-238 (H1N1) Antigen (Formaldehyde Inactivated); Influenza B Virus B/Michigan/01/2021 Antigen (Formaldehyde Inactivated); Influenza B Virus B/Phuket/3073/2013 Antigen (Formaldehyde Inactivated) |
| Marketing Category | BLA |
Unless explicitly stated in writing, no direct affiliation, sponsorship, or endorsement by individual product manufacturers with Premium Rx National, LLC should be implied. All brand names, trade names, and trademarks are the property of their respective owners and are presented solely for accurate product identification and informational reference.
NDC snapshot
INFLUENZA A VIRUS A/Victoria/4897/2022 IVR-238 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/Croatia/10136RV/2023 X-425A ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/MICHIGAN/01/2021 ANTIGEN (FORMALDEHYDE INACTIVATED) 15 ug / .5mL; 15 ug / .5mL; 15 ug / .5mL; 15 ug / .5mL Injection is tracked under NDC 49281-0541-15 and rolls up into product family 49281-0541. Use this page to confirm the exact presentation before moving into related family or manufacturer pathways.
- Package configuration: 1 Vial, Multi-Dose.
- Manufacturer: Sanofi Pasteur Inc..
- Dosage form: Injection.
- Family size: 1 active presentation.
Click a tag to refine the catalog view around this exact presentation.
Official references
Use official labeling and directory references to confirm presentation details while your team reviews the PRN catalog entry and related sourcing paths.
INFLUENZA A VIRUS A/Victoria/4897/2022 IVR-238 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/Croatia/10136RV/2023 X-425A ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/MICHIGAN/01/2021 ANTIGEN (FORMALDEHYDE INACTIVATED) 15 ug / .5mL; 15 ug / .5mL; 15 ug / .5mL; 15 ug / .5mL Injection 5 mL (Fluzone Quadrivalent Northern Hemisphere), NDC 49281-0541-15, is a Sanofi Pasteur Inc. 15 ug / .5mL; 15 ug / .5mL; 15 ug / .5mL; 15 ug / .5mL injection presentation packaged as 1 Vial, Multi-Dose.
NDC search formats
- Canonical NDC 11: 49281-0541-15.
- Digits-only NDC 11: 49281054115.
- Possible 10-digit display format: 49281-541-15 (4928154115).
Helpful product links
- Search by brand name: Fluzone Quadrivalent Northern Hemisphere.
- Exact NDC 11: 49281-0541-15.
- Product family NDC: 49281-0541.